ANGELA MCBROOM: Open Payments
NPI 1235433780 · AMARILLO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,946 in 95 payments from 20 companies in 2025. Trend: 2023 $48 · 2024 $108 · 2025 $1,946
Food & beverage: $1,946
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $310 |
| Otsuka America Pharmaceutical, Inc. | 7 | $218 |
| Novo Nordisk Inc | 10 | $181 |
| Axsome Therapeutics, Inc. | 9 | $155 |
| Bayer Healthcare Pharmaceuticals Inc. | 7 | $154 |
| ABBVIE INC. | 8 | $148 |
| Lilly USA, LLC | 9 | $140 |
| Corium, LLC | 5 | $119 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $82 |
| Teva Pharmaceuticals USA, Inc. | 4 | $79 |
Products named: REXULTI, Kerendia, AIRSUPRA, MOUNJARO, Azstarys, UBRELVY, BREZTRI, Rybelsus.
Industry payments across TX — which companies pay providers there.
